Research Effect
Supports lipolysis, fat oxidation, and reduced adipose tissue.
17 peptides documented with this effect
Research peptides documented to exhibit Fat Loss effects in scientific studies.
Also known as: Anti-Obesity Drug 9604, Tyr-hGH Fragment 177-191
A modified fragment of human growth hormone (amino acids 177-191) that retains the fat-reducing activity of GH without its growth-promoting or diabetogenic effects.
Also known as: IPA, NNC 26-0161
A highly selective growth hormone secretagogue that stimulates GH release through ghrelin receptor activation with minimal impact on cortisol and prolactin.
Also known as: GRF 1-29, Geref
The shortest fully functional fragment of GHRH, FDA-approved for diagnosing and treating growth hormone deficiency in children.
Also known as: Egrifta, TH9507
An FDA-approved GHRH analog specifically indicated for reducing visceral adipose tissue in HIV-associated lipodystrophy.
Also known as: Growth Hormone Releasing Peptide-6, SKF-110679
A first-generation growth hormone secretagogue that stimulates GH release through ghrelin receptor activation and is known for significantly increasing appetite.